| Product Code: ETC8868908 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland Oncology NGS Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland Oncology NGS Market Revenues & Volume, 2021 & 2031F |
3.3 Poland Oncology NGS Market - Industry Life Cycle |
3.4 Poland Oncology NGS Market - Porter's Five Forces |
3.5 Poland Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Poland Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Poland Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.8 Poland Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.9 Poland Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Poland Oncology NGS Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of cancer cases in Poland |
4.2.2 Growing adoption of precision medicine in oncology |
4.2.3 Technological advancements in next-generation sequencing (NGS) technologies |
4.2.4 Rising demand for personalized treatment options in oncology |
4.3 Market Restraints |
4.3.1 High costs associated with NGS testing |
4.3.2 Limited reimbursement policies for NGS-based oncology tests |
4.3.3 Data privacy and security concerns related to genomic data |
4.3.4 Lack of standardized guidelines for NGS testing in oncology |
5 Poland Oncology NGS Market Trends |
6 Poland Oncology NGS Market, By Types |
6.1 Poland Oncology NGS Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Poland Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Poland Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Poland Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.2 Poland Oncology NGS Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Poland Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F |
6.2.3 Poland Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F |
6.3 Poland Oncology NGS Market, By Service |
6.3.1 Overview and Analysis |
6.3.2 Poland Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F |
6.3.3 Poland Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F |
6.4 Poland Oncology NGS Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 Poland Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.4.3 Poland Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.4.4 Poland Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F |
6.5 Poland Oncology NGS Market, By End-use |
6.5.1 Overview and Analysis |
6.5.2 Poland Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F |
6.5.3 Poland Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F |
6.5.4 Poland Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.5.5 Poland Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F |
6.5.6 Poland Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F |
7 Poland Oncology NGS Market Import-Export Trade Statistics |
7.1 Poland Oncology NGS Market Export to Major Countries |
7.2 Poland Oncology NGS Market Imports from Major Countries |
8 Poland Oncology NGS Market Key Performance Indicators |
8.1 Average turnaround time for NGS test results |
8.2 Rate of adoption of NGS technologies in oncology clinics |
8.3 Number of clinical trials incorporating NGS technology |
8.4 Patient satisfaction with NGS testing experience |
9 Poland Oncology NGS Market - Opportunity Assessment |
9.1 Poland Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Poland Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Poland Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F |
9.4 Poland Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.5 Poland Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Poland Oncology NGS Market - Competitive Landscape |
10.1 Poland Oncology NGS Market Revenue Share, By Companies, 2024 |
10.2 Poland Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here